Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development
Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development
复制标题
DOI:
10.1038/ejhg.2008.269
复制
发表时间:
2009-08
影响因子:
5.2
通讯作者:
Litu Zhang;Z. Tümer;K. Møllgård;G. Barbi;E. Rossier;E. Bendsen;R. Møller;R. Ullmann;Jian He;N. Papadopoulos;N. Tommerup;L. Larsen
中科院分区:
文献类型:
--
作者:
Litu Zhang;Z. Tümer;K. Møllgård;G. Barbi;E. Rossier;E. Bendsen;R. Møller;R. Ullmann;Jian He;N. Papadopoulos;N. Tommerup;L. Larsen
The chromosome break points of the t (8; 21)(q21. 3; q22. 12) translocation associated with acute myeloid leukemia disrupt the RUNX1 gene (also known as AML1) and the RUNX1T1 gene (also known as CBFA2T3, MTG8 and ETO) and generate a RUNX1–RUNX1T1 fusion protein. Molecular characterization of the translocation break points in at (5; 8)(q32; q21. 3) patient with mild-to-moderate mental retardation and congenital heart disease revealed that one of the break points was within the RUNX1T1 gene. Analysis of RUNX1T1 expression in human embryonic and fetal tissues suggests a role of RUNX1T1 in brain and heart development and support the notion that disruption of the RUNX1T1 gene is associated with the patient's phenotype.